Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Policy

GSK Report Details Aid To Poor Nations

by Rick Mullin
March 30, 2009 | A version of this story appeared in Volume 87, Issue 13

GlaxoSmithKline's 2008 corporate responsibility report, published last week, states that the firm will contribute 500 granted and 300 pending patents to an intellectual property pool for research on treating neglected tropical diseases. The patent pool was proposed by CEO Andrew Witty at Harvard University last month (C&EN, Feb. 23, page 8). GSK also restated Witty's commitment to reducing the cost of drugs for the least developed countries to 25% of their cost in developed countries, as long as the firm can recoup the cost of goods.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.